CXCL1 as a novel prognostic biomarker and immune regulator in colon adenocarcinoma
Abstract Introduction Colon Adenocarcinoma (COAD) remains a prominent problem among cancers today. COAD is one of the malignancies with a significant overexpression of CXCL1, an enzyme involved in cellular metabolism. However, the key targets for colon cancer are not yet well understood. As a result...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer
2026-02-01
|
| Σειρά: | Discover Oncology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1007/s12672-026-04522-2 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|